awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38042439-36E0B7D6-F2A9-432E-839E-5DFCF818EC84
Q38042439-36E0B7D6-F2A9-432E-839E-5DFCF818EC84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38042439-36E0B7D6-F2A9-432E-839E-5DFCF818EC84
Selection of rituximab dosage in chronic lymphocytic leukemia: where is the evidence?
P2860
Q38042439-36E0B7D6-F2A9-432E-839E-5DFCF818EC84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38042439-36E0B7D6-F2A9-432E-839E-5DFCF818EC84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
12dc9ac5ca443942f73e2ff05dba1af8021cd5d3
P2860
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.